labie L Baseline Clinical and Angiographic Core Laboratory Characteristics.*
Characteristic |
PCI Group (N = 1082) |
Medical Therapy Group (N = 1084) |
P Value |
Clinical | |||
Age — yr |
58.6±10.8 |
58.7*11.1 |
0.78 |
Sex — no. (%) |
0.94 | ||
Małe |
845 (78) |
845 (78) | |
Female |
237 (22) |
239 (22) | |
Race or ethnic group — no. (%)f |
0.55 | ||
White |
874 (81) |
864 (80) | |
Black |
32 (3) |
35(3) | |
Hispanic |
137 (13) |
133 (12) | |
Other |
39(4) |
52(5) | |
History — no./total no. (%) | |||
Angina |
236/1081 (22) |
252/1084 (23) |
0.43 |
Myocardial infarction |
127/1082 (12) |
117/1084 (11) |
0.49 |
Cerebrovascular disease |
46/1081 (4) |
32/1084 (3) |
0.10 |
Peripheral-vessel disease |
42/1081 (4) |
39/1082 (4) |
0.73 |
Heart failure |
26/1081 (2) |
24/1082 (2) |
0.77 |
PCI |
51/1081 (5) |
53/1084 (5) |
0.85 |
CABG |
5/1082 (0.5) |
4/1084 (0.4) |
0.74 |
Diabetes |
200/1082 (18) |
246/1084 (23) |
0.02 |
Insulin use |
63/1082 (6) |
59/1084 (5) |
0.70 |
Hypertension |
519/1082 (48) |
536/1084 (49) |
0.49 |
Current cigarette smoker — no./total no. (%) |
423/1082 (39) |
427/1084 (39) |
0.89 |
Highest Killip class II through IV during index Ml — no./ total no. (%) |
219/1077 (20) |
194/1076 (18) |
0.17 |
NYHA classification at randomization — no./total no. (%) 1 |
898/1079 (83) |
900/1081 (83) |
0.98 |
II |
181/1079 (17) |
181/1081 (17) | |
New Q waves |
720/1082 (67) |
727/1084 (67) |
0.80 |
ST-segment elevation |
700/1037 (68) |
681/1039 (66) |
0.34 |
ST-segment elevation or Q-wave or R-wave loss |
939/1082 (87) |
932/1084 (86) |
0.58 |
Glomerular filtration ratę — ml/min^; |
80.8*21.4 |
80.6*21.9 |
0.83 |
Thrombolytic therapy during first 24 hr after onset of index Ml — no./total no. (%) |
225/1081 (21) |
195/1084 (18) |
0.10 |
lnterval between Ml and randomization — days| |
0.68 | ||
Median |
8 |
8 | |
25th percentile, 75th percentile |
5, 16 |
5, 17 | |
Stress test performed — no./total no. (%)1j |
290/1082 (27) |
299/1084 (28) |
0.68 |
Ischemia in infarct-related artery territory — no./total no. (%) |
0.22 | ||
Severe (ineligible) |
0/290 (0) |
1/299 (0.3) | |
Moderate |
27/290 (9) |
32/299 (11) | |
Mild |
98/290 (34) |
80/299 (27) | |
Nonę |
165/290 (57) |
186/299 (62) |